Cingulate
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cingulate and other ETFs, options, and stocks.About CING
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
CEOShane J. Schaffer
CEOShane J. Schaffer
Employees13
Employees13
HeadquartersKansas City, Kansas
HeadquartersKansas City, Kansas
Founded2012
Founded2012
Employees13
Employees13
CING Key Statistics
Market cap38.20M
Market cap38.20M
Price-Earnings ratio-1.02
Price-Earnings ratio-1.02
Dividend yield—
Dividend yield—
Average volume329.24K
Average volume329.24K
High today$5.43
High today$5.43
Low today$5.06
Low today$5.06
Open price$5.33
Open price$5.33
Volume197.29K
Volume197.29K
52 Week high$6.74
52 Week high$6.74
52 Week low$3.20
52 Week low$3.20
Stock Snapshot
With a market cap of 38.2M, Cingulate(CING) trades at $5.13. The stock has a price-to-earnings ratio of -1.02.
On 2026-01-23, Cingulate(CING) stock moved within a range of $5.06 to $5.43. With shares now at $5.13, the stock is trading +1.4% above its intraday low and -5.5% below the session's peak.
Trading activity shows a volume of 197.29K, compared to an average daily volume of 329.24K.
Over the past 52 weeks, Cingulate(CING) stock has traded between a high of $6.74 and a low of $3.20.
Over the past 52 weeks, Cingulate(CING) stock has traded between a high of $6.74 and a low of $3.20.
People also own
Based on the portfolios of people who own CING. This list is generated using Robinhood data, and it’s not a recommendation.